These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3145526)

  • 1. Pharmacological characterization of the physostigmine stimulus in rats.
    Jung M; Perio A; Worms P; Soubrie P
    Psychopharmacology (Berl); 1988; 95(4):553-5. PubMed ID: 3145526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminative stimulus properties of physostigmine in rats.
    Tang AH; Franklin SR
    Eur J Pharmacol; 1988 Aug; 153(1):97-104. PubMed ID: 3215280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the discriminative stimulus effects of physostigmine in the rat.
    Locke KW; Gorney B; Cornfeldt M; Fielding S
    J Pharmacol Exp Ther; 1989 Jul; 250(1):241-6. PubMed ID: 2746500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the scopolamine stimulus in rats.
    Jung M; Perio A; Worms P; Biziere K
    Psychopharmacology (Berl); 1988; 95(2):195-9. PubMed ID: 3137597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus properties of NIK-247 and tetrahydroaminoacridine, centrally active cholinesterase inhibitors, in rats.
    Yamamoto T; Ohno M; Sugimachi K; Ueki S
    Pharmacol Biochem Behav; 1993 Apr; 44(4):769-75. PubMed ID: 8469688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylcholinesterase inhibitors partially generalize to nicotine discriminative stimulus effect in rats.
    Giarola A; Auber A; Chiamulera C
    Behav Pharmacol; 2011 Feb; 22(1):1-6. PubMed ID: 21116174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminative stimulus properties of muscarinic agonists.
    Jung M; Costa L; Shearman GT; Kelly PH
    Psychopharmacology (Berl); 1987; 93(2):139-45. PubMed ID: 3122245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of cholinergic drugs on discriminative cues and self-stimulation produced by electrical stimulation of the ventral tegmental area.
    Druhan JP; Fibiger HC; Phillips AG
    Psychopharmacology (Berl); 1989; 97(3):331-8. PubMed ID: 2497481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological specificity of N-methyl-D-aspartate discrimination in rats.
    Grech DM; Willetts J; Balster RL
    Neuropharmacology; 1993 Apr; 32(4):349-54. PubMed ID: 8098862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats.
    Shannon HE; Bemis KG; Hendrix JC; Ward JS
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1071-7. PubMed ID: 2262893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative stimulus properties of arecoline: a new approach for studying central muscarinic receptors.
    Meltzer LT; Rosecrans JA
    Psychopharmacology (Berl); 1981; 75(4):383-7. PubMed ID: 6803285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymmetric generalization between the discriminative stimulus effects of nicotine and cocaine.
    Desai RI; Barber DJ; Terry P
    Behav Pharmacol; 1999 Nov; 10(6-7):647-56. PubMed ID: 10780506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemicholinium-3 impairs spatial learning and the deficit is reversed by cholinomimetics.
    Hagan JJ; Jansen JH; Broekkamp CL
    Psychopharmacology (Berl); 1989; 98(3):347-56. PubMed ID: 2526345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine and arecoline as discriminative stimuli: involvement of a non-cholinergic mechanism for nicotine.
    Meltzer LT; Rosecrans JA
    Pharmacol Biochem Behav; 1988 Mar; 29(3):587-93. PubMed ID: 3362953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scopolamine-physostigmine combination does not substitute for nicotine.
    Schechter MD
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 May; 19(3):499-508. PubMed ID: 7624500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of physostigmine and cholinergic receptor ligands on novelty-induced neophobia.
    Sienkiewicz-Jarosz H; Członkowska AI; Siemiatkowski M; Maciejak P; Szyndler J; Płaźnik A
    J Neural Transm (Vienna); 2000; 107(12):1403-12. PubMed ID: 11458993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine mechanisms play at best a small role in the nicotine discriminative stimulus.
    Corrigall WA; Coen KM
    Pharmacol Biochem Behav; 1994 Jul; 48(3):817-20. PubMed ID: 7938142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral effects after intrathecal administration of cholinergic receptor agonists in the rat.
    Gillberg PG; Hartvig P; Gordh T; Sottile A; Jansson I; Archer T; Post C
    Psychopharmacology (Berl); 1990; 100(4):464-9. PubMed ID: 2320707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative stimulus properties of pentylenetetrazol and bemegride: some generalization and antagonism tests.
    Shearman G; Lal H
    Psychopharmacology (Berl); 1979 Sep; 64(3):315-9. PubMed ID: 41279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intracerebroventricular pirenzepine on muscarinic discriminations in rats.
    Jung M; Perio A; Terranova JP; Worms P; Biziere K
    Eur J Pharmacol; 1987 Jul; 139(1):111-6. PubMed ID: 3653237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.